ArticleAngewandte Chemie (International ed. in English)2026
Thermostable Bioluminescent Intercalating Dyes for Real-Time, Integrated Nucleic Acid Amplification and Detection.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Integrated nucleic acid amplification and detection methods that can be conducted at the point of care are critical to advancing infectious disease diagnostics. We previously developed luciferase-intercalating dye conjugates ("LUMIDs") that allow for direct detection of double-stranded DNA (dsDNA) through a simple, ratiometric bioluminescent readout. However, their limited thermostability hampers integration with isothermal nucleic acid amplification methods that provide the specificity and sensitivity required for diagnostics. In this work, we re-engineered LUMID to allow for one-pot integration with loop-mediated isothermal amplification (LAMP) and real-time monitoring of DNA amplification. Luciferase activity and DNA binding were retained at LAMP temperatures (60°C-65°C) by employing a thermostable NanoLuc luciferase variant and an additional thermostable DNA binding protein. To enable continuous monitoring, we additionally introduced a caged luciferin substrate with esterase-controlled release kinetics for sustained light output. These combined advances enabled one-pot LAMP-LUMID assays to detect cancer-associated human papillomavirus (HPV) subtypes with attomolar sensitivity and within ∼ 30 min. Using a simple digital camera as readout, LAMP-LUMID demonstrated robust assay performance in patient samples, showcasing its potential as a rapid and sensitive platform for molecular diagnostics that is particularly attractive for low-resource settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.